Alteplase Use in Surface-Modified Peripherally Inserted Central Catheters in a National Cancer Institute-Designated Comprehensive Cancer Center: A Pharmacoeconomic Analysis
详细信息 查看全文
- 作者：Eric R. Musial ; PharmD ; ermusial@hotmail.com" class="auth_mail" title="E-mail the corresponding author ; Lamya Hamad ; MPH ; Chong Wang ; MA ; Ryan Hare ; PharmD
- 关键词：Bioflow ; Endexo ; peripherally inserted central catheter
- 刊名：Journal of the Association for Vascular Access
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：21
- 期：1
- 页码：39-43
- 全文大小：133 K
文摘
- •
We compared two PICCs, a standard of care PICC and a PICC manufactured with EndexoTM technology. We followed each line for 60 days and assessed alteplase usage.
- •
We found no statistical difference in alteplase usage between groups, or time to first dose of alteplase.
- •
The increased cost of an EndexoTM PICC does not seem to be offset by a reduction in alteplase usage.
- •
More research is need to assess the efficacy of an EndexoTM PICC at reducing thrombotic complications.